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Urinary arsenic profiles reveal 
exposures to inorganic arsenic from 
private drinking water supplies in 
Cornwall, UK
D. R. S. Middleton1,2,3, M. J. Watts2, E. M. Hamilton2, E. L. Ander2, R. M. Close3, K. S. Exley3, 
H. Crabbe3, G. S. Leonardi3, T. Fletcher3 & D. A. Polya1
Private water supplies (PWS) in Cornwall, South West England exceeded the current WHO guidance 
value and UK prescribed concentration or value (PCV) for arsenic of 10 μg/L in 5% of properties 
surveyed (n = 497). In this follow-up study, the first of its kind in the UK, volunteers (n = 207) from 127 
households who used their PWS for drinking, provided urine and drinking water samples for total As 
determination by inductively coupled plasma mass spectrometry (ICP-MS) and urinary As speciation 
by high performance liquid chromatography ICP-MS (HPLC-ICP-MS). Arsenic concentrations exceeding 
10 μg/L were found in the PWS of 10% of the volunteers. Unadjusted total urinary As concentrations 
were poorly correlated (Spearman’s ρ = 0.36 (P < 0.001)) with PWS As largely due to the use of spot 
urine samples and the dominance of arsenobetaine (AB) from seafood sources. However, the osmolality 
adjusted sum, U-AsIMM, of urinary inorganic As species, arsenite (AsIII) and arsenate (AsV), and their 
metabolites, methylarsonate (MA) and dimethylarsinate (DMA), was found to strongly correlate 
(Spearman’s ρ: 0.62 (P < 0.001)) with PWS As, indicating private water supplies as the dominant source 
of inorganic As exposure in the study population of PWS users.
Chronic exposure to arsenic (As) in drinking water is a well-documented cause of numerous cancerous and 
non-cancerous health defects1, including cancers of the lung, bladder and skin. While most cases of chronic As 
exposure in drinking water have been reported in Bangladesh and West Bengal2,3, countries on all continents are 
affected4. Recent studies have identified lower (e.g.< 150 As μ g/L) exposures in European and North American 
populations in both municipal and private supplies in rural locations where centralized treated water supply has 
not been implemented. Examples of this scenario include Serbia5, Hungary6, Romania7, Slovakia7 and the USA8, 
where for the latter it is estimated that approximately 15% of the population rely on private groundwater supplies 
(PWS)9, and as much as 40% of people in New Hampshire, Vermont and Maine10. Many communities in rural 
parts of the UK also use PWS and a reported 567,261 people in the UK live or work in properties served by PWS11.
One area warranting further investigation is Cornwall in South West England, where PWS usage is estimated 
to range from 20,000–30,000 wells12 although only 2,462 single domestic PWS are currently registered on the 
Drinking Water Inspectorate (DWI) database11. Cornwall’s diverse geology and extensive history of mineral 
exploitation make it a region of elevated environmental inorganic As13, with an estimated 722 km2 of As contam-
inated land14. Elevated concentrations have previously been reported in soils15,16, stream waters17/sediments18 
and household dusts19,20. In 2010, the Private Water Supplies Regulations (2009)21 came into force and prompted 
an initiative to investigate the possible public health implications of PWS consumption. The abovementioned 
findings and the high frequency of PWS in Cornwall relative to most of the UK led to its selection for a study22 
investigating the trace metal content of UK PWS. This study found As in PWS drinking water exceeding the 
10 As μ g/L UK prescribed concentration or value23 (PCV) in 27 out of 497 (5%) households22. This suggests that 
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a considerable number of people in the region may be subject to elevated levels of As in their drinking water, an 
exposure route not comprehensively investigated in Cornwall, nor indeed the UK as a whole, to date.
The identification of elevated concentrations of As in drinking water alone can help provide an indication 
of the population at risk. However, the use of exposure biomonitoring, the analysis of biological material for 
the presence of chemicals and their metabolites, allows for a more direct quantification of internal exposure24 
underpinning environmental chemical attributable health risks. A common approach to As biomonitoring is 
the analysis of urine samples for inorganic arsenite (AsIII), arsenate (AsV) and methylated metabolites methylar-
sonate (MA) and dimethylarsinate (DMA) that are excreted in the urine following metabolism in the liver25. It 
is accepted that post intake, inorganic AsV is reduced to AsIII followed by methylation to MA and DMA26. The 
process was formerly considered to be a detoxification pathway, but findings of genotoxic intermediate trivalent 
forms of MA and DMA suggest otherwise27. The exact mechanisms of As biomethylation are subject to ongoing 
investigation28. For the purpose of exposure assessment, the methylation of inorganic to organic As species jus-
tifies the quantification of MA and DMA, whilst acknowledging that direct intake of both of these species from 
dietary sources has been reported29. The majority of As is excreted within 4 days of dosage30, making urinary As 
a useful measure of recent exposure, and has been used, for example, to demonstrate rice as a significant dietary 
exposure pathway in rice consumers in the UK31, USA32 and West Bengal33. Several studies have used urinary 
As to model the risk of health end-points and toxicological responses resulting from exposure to inorganic As. 
These include type 2 diabetes34, a mortality follow-up of a population with baseline urine measurements which 
found a significant association with lung cancer35 and increased genotoxicity measured by micronuclei frequency 
in urothelial cells36. Urinary As biomonitoring, albeit on a small number of volunteers and in relation to soil and 
dust exposure, has been carried out in Cornwall on two previous occasions37,38 and elevated concentrations were 
observed relative to control areas with low environmental As.
A number of considerations need to be taken into account when urinary As is used as a biomarker of 
exposure. Firstly, total urinary As results can be influenced by high concentrations of arsenobetaine (AB), an 
organo-arsenical found in seafood, widely thought to be non-toxic39 and readily excreted unaltered following 
dietary intake. This makes it necessary to perform speciation analysis on urine samples to quantify the individual 
As species and exclude the contribution from AB which does not reflect exposure to more hazardous environ-
mental inorganic As. Secondly, the variation in hydration status among volunteers means that both first morning 
void (FMV) and spot urine samples differ markedly in their dilution, both giving imperfect estimates of 24 hr 
excretion40. Therefore, in order to be used as a robust indicator of exposure, urinary As concentrations require 
adjustment for dilution to eliminate variation from fluid balance. Creatinine and specific gravity (SG) adjust-
ment are widely used, but both methods are susceptible to interferences. Variation in urinary creatinine has been 
demonstrated between demographic groups41 and in response to variations in muscle mass42 and malnutrition43, 
while possibly a more relevant deterrent of applying this adjustment factor is its observed relationship with As 
methylation efficiency44. Alternatively, because SG is routinely measured by refractometry, the presence of uri-
nary solutes such as protein (proteinuria), glucose (glucosuria) and ketones (ketonuria) alters the refractive index 
of the liquid irrespective of its dilution, thus giving inaccurate dilution estimates45. One alternative adjustment 
factor, seldom used in biomonitoring studies, is urinary osmolality. Previously overlooked due to the lack of wide-
spread availability and relative cost of the instrumentation required46, osmolality is regarded as the ‘gold standard’ 
and definitive measure of urinary concentration in the clinical and veterinary sciences community47. In the case 
of cryoscopic osmometry, freezing point depression is measured. Freezing point is a colligative property reflective 
of solute content, expressed here by osmolality (osmoles of solute per mass unit of solvent) and is not vulnerable 
to the same interferences as SG measurement by refractometry. Given the absence of 24 hr or timed excretion data 
in the present study, osmolality adjustment was preferred over the two alternative options.
This study aimed to: (1) assess human exposure to inorganic environmental As in a population of PWS users 
in Cornwall using non-invasive urinary As exposure biomonitoring, (2) assess to what extent the biomarker 
response can be attributed to PWS drinking water as an exposure route and (3) observe the effect of osmolality 
adjustment to better define the relationship between urinary As and PWS drinking water As.
Results
Study group demographics. The extent of the study area and spatial distribution of households is shown 
in Fig. 1. A total of 215 volunteers from 129 households participated in the study. Of these volunteers, 207 from 
127 households consisting of 108 males (52%) and 99 females (48%), reported using their water for drinking and 
provided both a drinking water and urine sample. Henceforth, unless otherwise stated, this sub-group will be the 
focus of the present article. The mean volunteer age was 62 years old (range: 18–90). The age and gender distribu-
tion is shown in Fig. 2. The study group was classified as a 99% rural population (see supplementary information).
PWS drinking water and urine samples. Summary statistics for total As in drinking water samples and 
total and speciated As in urine samples (unadjusted and osmolality adjusted) are displayed in Table 1 and plot-
ted in Fig. 3. Geometric means (GM) were calculated in addition to arithmetic means (AM) as the data were 
positively skewed. Of the 127 households, 126 (99%) had detectable (> 0.02 μ g/L) As in their drinking water, 62 
(49%) had ≥1 μ g/L and 15 (12%) exceeded the current WHO guidance value48 and UK PCV23 of 10 μ g/L. This 
corresponds to 21 of the 207 (10%) volunteers being exposed to drinking water As concentrations above 10 μ g/L. 
The maximum PWS drinking water arsenic concentration was 233 μ g/L.
All volunteers had detectable (> 0.2 μ g/L) concentrations of unadjusted urinary total As; with a maximum 
observed concentration of 426 μ g/L. Speciation data yielded a 98% mean recovery of total As and precision, 
expressed as relative standard deviation (RSD), was 9%. Despite requesting volunteers to refrain from eating sea-
food for the 4 days prior to sample collection, a large contribution of total As was from organic AB. Arsenobetaine 
was detected (LOD 1.3 μ g/L) in 152 (73%) samples whilst the mean contribution of AB to total urinary As was 
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49%; (range: 0–98%). Findings of inorganic AsIII and AsV were lower, with 56 (27%) and 10 (5%) of samples 
having detectable concentrations (> 0.8 μ g/L; > 1.5 μ g/L) respectively. The sum of AsIII and AsV ranged from 
< LOD (0.8 μ g/L and 1.5 μ g/L respectively) to 19.2 μ g/L. All samples had detectable concentrations of DMA and 
107 (52%) had detectable concentrations of MA. Dimethylarsinate was the dominant arsenic species with the 
exception of AB. The sum of inorganic As (AsIII and AsV) and its organic methylated metabolites (MA and DMA), 
referred to here as U-AsIMM, ranged from 0.9 to 124 μ g/L with an arithmetic mean (AM) of 9.0 μ g/L and a GM of 
5.8 μ g/L.
Urinary osmolality ranged from 181–1161 mOsm/kg, reflecting a large variation in urinary dilution amongst 
volunteers. Post osmolality adjustment, AM urinary total As moderately decreased from 36.8 to 36.1 μ g/L and the 
GM slightly increased from 15.8 to 17.1 (range: 2.2–404 μ g/L). The osmolality adjusted U-AsIMM AM and GM also 
decreased to 8.6 and increased to 6.3, respectively.
Additionally, 30 (14%) urine samples were collected as spot samples at the time of visit as opposed to first 
morning voids (FMV). To address this, a Welch’s independent two-group t-test was used to assess the difference 
between the two collection methods. For unadjusted and osmolality adjusted U-AsIMM and urinary osmolality no 
significant difference was observed (P = 0.20, P = 0.30 and p = 0.43, respectively).
Figure 1. Spatial distribution of sampled households. Compiled using ArcMap 10.1.
Figure 2. Study group age and gender distribution. While population risk assessment is not the focus of this 
aspect of the study, it is noted for future reference that the present sample is not wholly representative of the 
underlying population of rural Cornwall. *Office for National Statistics (ONS) Rural-urban classification 2011 
(RUC11) was used to determine the underlying population (see supplementary information). Adapted from 
data from the Office for National Statistics licensed under the Open Government Licence v.3.0.
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Correlation analysis. Scatterplots showing urinary As vs PWS drinking water total As, both before and after 
AB and dilution adjustment, are shown in Fig. 4. Figure 4a shows that total As in drinking water was not a good 
predictor of urinary total As, with a large variation in urinary total As even for volunteers with low PWS drinking 
water As concentrations. However, when corrected for AB (Fig. 4b) a more positive correlation was observed. 
Correcting for urinary dilution using osmolality measurements further improved the correlation between urinary 
As (U-AsIMM) and PWS drinking water As (Fig. 4c). To test the strength of these correlations, Spearman’s rank 
correlation coefficient was used as both variables were non-normally distributed (Shapiro-Wilk test: P < 0.001 
for drinking water total As, and both unadjusted and osmolality adjusted urinary total and U-AsIMM) and the 
results from this analysis are shown in Table 2. Following adjustment for AB, a stronger correlation was observed 
between drinking water and urine samples (Spearman’s ρ = 0.36 (P < 0.001) and 0.58 (P < 0.001) pre and post AB 
exclusion respectively). This correlation strengthened slightly (Spearman’s ρ = 0.62, P < 0.001) following osmo-
lality adjustment. The correlation between creatinine adjusted U-AsIMM (μ g/g Cre) and drinking water As is also 
shown in comparison to unadjusted and osmolality adjusted results (Fig. 5) and is weaker (Spearman’s ρ = 0.53, 
P < 0.001) than both. In addition, correlations were calculated on subsets of different drinking water As con-
centrations and were found to weaken with decreasing concentration. For drinking water As versus osmolality 
corrected U-AsIMM, Spearman’s ρ was 0.81 (P < 0.001) when drinking water As was >10 μ g/L compared to 0.21 
(P = 0.031) when < 1μ g/L. This is shown in Fig. 6.
Finally, 74 households consisted of >1 volunteer, all of whom were included in correlation analyses. 
Volunteers (observations) sharing a household (sampling unit) were therefore not independent. Correlations 
between U-AsIMM concentrations of volunteers from the same household (n = 74) were calculated as ρ = 0.59 
(P < 0.001) and ρ = 0.66 (P < 0.001) for unadjusted and osmolality adjusted concentrations, respectively. This 
had the potential to influence the strength of correlations and, therefore, correlations were re-calculated by ran-
domly selecting one volunteer per household for inclusion. These results are presented in Table 3 and, although 
some correlations (particularly those calculated for lower drinking water As concentration groups) were numer-
ically different, the overall pattern remained the same. Furthermore, the correlations re-calculated on osmolality 
adjusted U-AsIMM concentrations agreed strongly across drinking water concentrations groups with those origi-
nally calculated with the inclusion of all volunteers.
Discussion
The present study shows that exposure to inorganic As in drinking water, although not widespread, is occurring 
within the Cornwall study population with 10% of the present study group exposed to > 10 μ g As/L in drinking 
water. Although not a true representation of the actual proportion of population exposure, this study builds on 
the findings22 of its precursor survey by confirming human exposure from PWS that exceeded the PCV, with high 
As concentrations in drinking water reflected by dilution and AB adjusted U-AsIMM.
The maximum U-AsIMM concentration measured in the present study (124 μ g/L) was comparable with val-
ues found in West Bengal49, one of the world’s worst affected regions, some of the highest recorded elsewhere 
in Europe50, and was higher than any found previously in Cornwall37,51. In 1998 Kavanagh and co-workers51 
reported a range of 2.7–58.9 μ g As/g creatinine (U-AsIMM) in urine collected from residents (8 boys aged 3–8; 9 
adults aged 30–43) of Gunnislake, Cornwall, although the drinking water supply status of the volunteers was not 
reported. This demonstrates that the larger sample population in this study revealed further exposure incidences 
in the region and a previously uninvestigated exposure route, both in Cornwall and the UK to date.
Correlation analysis of exposure and response variables showed that the strength of the correlation between 
drinking water and U-AsIMM reduced with decreasing levels of exposure to total As in drinking water. Variation 
among U-AsIMM results in volunteers with < 1 μ g/L in drinking water was evident, with some urinary U-AsIMM 
n
Drinking 
water total As 
(μg/L)
Urinary 
total As 
(μg/L)
Urinary 
U-AsIMM 
(μg/L)
Urinary 
AB (μg/L)
Urinary 
AsIII 
(μg/L)
Urinary 
AsV (μg/L)
Urinary 
MA (μg/L)
Urinary 
DMA 
(μg/L)
127 207 207 207 207 207 207 207
Unadjusted
 Arithmetic mean 7.0 37 9.0 26 0.7 0.5 1.3 6.5
 Geometric mean 1.0 16 5.8 6.2 0.6 0.8 0.7 4.3
 Median 0.9 15 5.3 6.9 0.3 0.3 0.7 4.0
 Min < LOD 1.6 0.9 < LOD < LOD < LOD < LOD 0.8
 Max 233 426 124 363 13 12 25 79
Osmolality Adjusted
 Arithmetic mean 36 8.6 26 0.6 0.5 1.2 6.3
 Geometric mean 17 6.3 6.5 0.6 0.8 0.7 4.7
 Median 15 5.7 7.3 0.4 0.3 0.8 4.4
 Min 2.2 1.7 < LOD < LOD < LOD < LOD 1.4
 Max 404 131 360 14 9.1 27 84
Table 1.  Descriptive statistics for drinking water and urinary arsenic concentrations. Drinking water As 
results are shown on the basis of collected samples/sampled supplies (n = 127). Between 1 and 4 volunteers were 
associated with any one drinking water sample. Urinary As results are shown both with and without osmolality 
adjustment.
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results still higher than 10 μ g/L. As mentioned, Cornwall is an area of high environmental As and these obser-
vations suggest that in low drinking water As concentration scenarios, confounding exposure variables such as 
direct soil ingestion from home grown produce consumption, dust ingestion/inhalation or contact with high As 
bearing mine wastes could be more prominent. The importance of these exposure routes will be the focus of fur-
ther research incorporating the analyses of garden/vegetable patch soils and household dust.
Figure 3. Box and whisker plots of private water supply (PWS) drinking water and urinary As. (a) Total As 
in drinking water samples plotted with its analytical limit of detection (LOD) (lower dashed line) and the UK As 
PCV (upper solid line). (b) Individual urinary As species plotted with their respective LODs (dashed lines).  
(c) Urinary total As and urinary sum of species excluding AB (U-AsIMM). Boxes range from 1st to 3rd quartiles 
with a median line, lower and upper whiskers are the lowest and highest datum within 1.5 inter quartile range 
(IQR) of the lowest and upper quartile respectively and circles are outliers. For plotting purposes, speciation 
data were censored by replacing < LOD values with ½ LOD.
Figure 4. Unadjusted and adjusted urinary As – PWS drinking water As. (a) Unadjusted urinary total As. 
(b) Unadjusted U-AsIMM (adjusted for AB). (c) Osmolality adjusted U-AsIMM. Linear regression lines are for 
reference only. A poor relationship between drinking water total As and unadjusted urinary total As is evident 
(a) due to seafood intake and the large contribution of AB on urinary total As results. This is illustrated by the 
red dashed line showing high urinary total As results at low drinking water As exposure.
Spearman’s ρ (P value)
Drinking Water 
As < 1 μg/L (n = 109)
Drinking Water As 
1–10 μg/L (n = 77)
Drinking Water 
As > 10 μg/L (n = 21)
Full range 
(n = 207)
Drinking Water As vs Urinary Total As 0.19 (P = 0.048) 0.36 (P = 0.001) 0.55 (P = 0.009) 0.36 (P < 0.001)
Drinking Water As vs U-AsIMM 0.18 (P = 0.060) 0.38 (P < 0.001) 0.69 (P < 0.001) 0.58 (P < 0.001)
Drinking Water As vs Osmolality 
Adjusted U-AsIMM 0.21 (P = 0.031) 0.49 (P < 0.001) 0.81 (P < 0.001) 0.62 (P < 0.001)
Table 2.  Correlation analysis of exposure and outcome variables for all volunteers. A strong correlation 
(bold font) is only observed for U-AsIMM (osmolality adjusted) for drinking water As > 10 μ g/L. All household 
volunteers were included in analyses.
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Additionally, with the exception of AB, DMA was the dominant species measured in urine samples. This is 
not unexpected, as DMA is the major endpoint of As metabolism in mammals, typically accounting for 60–80% 
of stable urinary As species excluding AB52. This outcome requires further consideration given the low drinking 
Figure 5. Comparison of alternative U-AsIMM adjustment methods. The comparison between unadjusted 
results (a), creatinine adjusted results (b) and osmolality adjusted results (c). The Spearman correlation is 
stronger in osmolality adjusted results than both alternatives.
Figure 6. Log-log plot of U-AsIMM vs PWS drinking water As divided into drinking water exposure 
levels. Variables from Fig. 3c plotted on log scale axes to show contrasting exposure-response relationships of 
participants exposed to different concentrations of As in drinking water. Spearman’s correlation coefficients (ρ ) 
are displayed for the different drinking water As ranges.
Spearman’s ρ (P value)
Drinking Water As 
<1 μg/L (n = 65)
Drinking Water As 
1–10 μg/L (n = 47)
Drinking Water As 
>10 μg/L (n = 15)
Full range 
(n = 127)
Drinking Water As 
vs Urinary Total As 0.27 (P = 0.03) 0.42 (P = 0.004) 0.48 (P = 0.07)
0.40 
(P < 0.001)
Drinking Water As 
vs U-AsIMM 0.23 (P = 0.06) 0.49 (P < 0.001) 0.69 (P = 0.005)
0.60 
(P < 0.001)
Drinking Water 
As vs Osmolality 
Adjusted U-AsIMM
0.19 (P = 0.13) 0.54 (P < 0.001) 0.82 (P < 0.001) 0.62 (P < 0.001)
Table 3.  Correlation analysis of exposure and outcome variables for single volunteers per household. 
A strong correlation (bold font) is only observed for U-AsIMM (osmolality adjusted) for drinking water As 
>10 μ g/L. One volunteer per household was chosen at random for inclusion in analyses.
www.nature.com/scientificreports/
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water concentrations of the majority of individuals. This is in agreement with the study of Leese et al.29 who 
reported high concentrations of AB in urine samples from an unexposed population29, in which DMA was also 
the dominant species after AB. Given the unexposed status of their study population, Leese et al.29 conclude that 
dietary sources are responsible for the presence of DMA as well as AB. In addition, they advise that organic meth-
ylated species in urine samples do not necessarily indicate exposure to inorganic As. In the case of individuals not 
exposed to As in their drinking water, future efforts should be made to model the proportion of DMA likely to 
derive from direct dietary intake versus that excreted as a product of the metabolism of inorganic species.
No robust reference value for U-AsIMM applicable to a UK population currently exists and existing values 
applicable elsewhere are discussed. Commonly cited is the Agency for Toxic Disease Registry (ATSDR) 100 μ g/L 
total urinary As53. This was not selected for comparison in the present study due to the large contribution of AB 
to urinary total As and unless seafood consumption can be categorically ruled out then this value is not recom-
mended. Of 207 urine samples, 12 (6%) exceeded 21.5 μ g/L of unadjusted U-AsIMM, the approximate creatinine 
adjusted concentration found in a recent study35 to correspond to a lung cancer hazard ratio (HR) of 2.0 which is 
equivalent to double the risk of developing the disease. This value is more appropriate for comparison as it is not 
affected by AB, however it is noted that because it refers to creatinine adjusted urinary As results from a sample of 
almost 4000 American Indians, it is not directly applicable to the group studied here. An arguably more appropri-
ate value is the occupational biological effect index (BEI) provided by the American Conference of Government 
Industrial Hygienists54 (ACGIH) (35 μ g/L of unadjusted U-AsIMM), of which 8 (4%) samples exceeded. Whilst 
acknowledging that this was derived for use with occupational exposure, the BEI was chosen as the comparison 
value provided to volunteers on feeding back their individual urinary As results (unadjusted U-AsIMM).
In order to assess the magnitude of exposure it is important to consider how the sample in the present study 
relates to the underlying population of PWS users in Cornwall and elsewhere in the UK. As demonstrated in 
Fig. 2a, the sample of volunteers obtained in the present study was biased and is unlikely to reflect the true 
proportion of exposure in the underlying population. Furthermore, high-As bearing PWS were over-sampled 
to ensure that a range of exposure scenarios were captured to model the biomarker response. Therefore, the 
proportion of drinking water As PCV exceedances in the present study is higher than that observed in the wider 
population of PWS users (12% in the present biomonitoring study versus 5% in the 2011–2013 PWS survey). 
The relationship between the current sample and the underlying population is a matter for further investigation.
Urinary As biomonitoring is useful in assessing recent exposure25, and therefore results offer a snapshot of a 
relatively narrow exposure window, especially given that FMV/spot samples were taken as opposed to 24 hr col-
lections, making it impossible to assess day-to-day variation in individual excretion patterns. Chronic exposure 
to As cannot be fully assessed by exposure incidence alone, an assessment of longevity is also needed. The analysis 
of alternative biomarkers such as hair and toenails is ongoing and may provide evidence of longer term exposure, 
as will analysis of the temporal stability of As in drinking water samples.
In conclusion, it has been demonstrated that, following the necessary adjustments of urinary As concentra-
tions for AB intake and urinary fluid balance, a strong positive correlation was observed between As concentra-
tions in PWS drinking water and urinary As excretion-indicative of ongoing human exposure to inorganic As in 
PWS drinking water in Cornwall. Given the comparisons to existing guidance values for other populations, the 
results of the present study are a cause for concern, albeit for a minority of cases. Efforts should be made to raise 
wider public awareness of the potential hazards associated with PWS usage and, where analytes exceed the PCV, 
recommendations for treatment should be made given that it has been demonstrated55 that installation of appro-
priate treatment systems is effective in reducing exposure to As and other elements. This work has raised points 
for further investigation which should include: whether chronic/long-term exposure is evident; the importance 
of additional exposure routes; further refinement of As biomonitoring techniques to account for dietary sources 
of organic As species in addition to AB; identification of specific population groups at risk. Such groups may be 
dictated geographically or as a result of individual susceptibility or behavioural risk factors. Particular ‘hotspots’ 
of high exposure require identification using spatial/geostatistical methods and ongoing questionnaire analysis. 
Finally, the health implications of PWS usage in the UK warrant more investigation by detailed analysis of supply 
distribution, consumption patterns, geochemical risk modelling in conjunction with health surveillance datasets.
Methods
Ethical approval and consent. In accordance with approved guidelines, written informed consent was 
obtained from all volunteers and only those who were able to provide such were included in the study. In addition, 
all methods were followed in accordance with approved guidelines. Ethical approval for the study was provided 
by the University of Manchester Research Ethics Committee (Ref 13068) and the NHS Health Research Authority 
National Research Ethics Committee (NRES) (Ref 13/EE/0234).
Sampling strategy and recruitment methods. The sampling frame consisted of volunteers previously 
involved in the 2011–2013 PWS survey carried out by the BGS on behalf of the former Health Protection Agency 
(HPA), now part of Public Health England (PHE). Households with a PWS at which volunteers resided formed 
the sampling units. Observational units consisted of those individual volunteers who met the following inclusion 
criteria: ≥ 18 years of age; did not suffer from a health condition that could prevent them from participating in 
the study; had not been identified from the previous phase as unwilling/unable to participate further; provided 
informed consent. Prospective volunteers were contacted via an information/invitation letter prior to receiving 
a telephone call. All of those with > 1 As μ g/L being found in their drinking water in the previous survey were 
contacted to include as many as possible in the study. Numbers were then made up with households in the < 1 As 
μ g/L category. This approach was designed to maximise the range of observed exposures in the study group.
www.nature.com/scientificreports/
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Sample collection and pre-treatment. Household visits were made to volunteers by sampling teams. 
Urine and point of use drinking water samples were collected and an exposure assessment questionnaire admin-
istered to volunteers using Microsoft Access 2007 on a laptop/tablet device to ascertain whether volunteers were 
using their PWS for drinking.
Drinking water samples were collected by running the tap most frequently used for drinking for a minimum 
of 3 minutes to purge any standing water from the pipes before collecting the water in pre-rinsed (with the water 
being sampled) LDPE containers (Nalgene, USA). Samples were stored in a cool box during transit. Samples were 
acidified with 1% v/v HNO3 on return to the field laboratory, and then with an additional 0.5% v/v of HCl on 
return to the Inorganic Geochemistry Facility at the British Geological Survey.
For urine collection, volunteers were asked to refrain from eating seafood for a minimum of 4 days prior to 
providing a sample. HDPE containers (60 mL) (Nalgene, USA) were mailed in advance to volunteers who were 
asked to provide a FMV, mid-stream urine sample on the day of their visit and store it in the refrigerator until 
collection by the sampling team. Where instructions were not followed (n = 30), a spot urine sample was collected 
at the time of the visit where possible. Samples were stored in a cool box during transit and, on return to the field 
laboratory, filtered through 0.45 μ m Acrodisc® syringe filters (PALL Life Sciences, USA) into 30 mL HDPE con-
tainers (Nalgene, USA) and then frozen at −30 °C until analysis.
Reagents and standards. The aqueous solutions used throughout the study were prepared using 18.2 MΩ 
deionised water (Millipore, UK). Nitric (HNO3) and hydrochloric (HCl) acids were Romil-SpA™ super purity 
grade (Romil, UK). Ammonium nitrate (NH4NO3) solutions were prepared from a solid stock of BioXtra ≥ 99.5% 
purity (Sigma-Aldrich, USA) and pH adjusted using Aristar® grade 25% ammonia (NH3) solution (BDH, UK). 
Arsenic calibration standards were prepared from an in-house multi-element stock in which the As contribu-
tion was from a 1000 mg/L PrimAg® grade mono-elemental stock solution (Romil, UK). Arsenic QC standards 
(5 μ g/L) were prepared from a multi-element stock solution of various concentrations with As at 20 mg/L (Ultra 
Scientific, USA). A Tellurium (Te) ICP-MS internal standard was prepared from a PlasmaCAL 10,000 mg/L stock 
solution (SCP Science, Canada). The following standards were used for the calibration of individual As species as 
follows: AsIII: 1000 As mg/L stock solution of arsenic trioxide (As2O3) (Inorganic Ventures, USA); Asv: 1000 As mg/L 
stock solution of arsenic (V) oxide hydrate (As2O5·xH2O) (Inorganic Ventures, USA); MA: 50 As mg/L in-house 
stock solution of monomethylarsonic acid ((CH3AsO(OH)2) prepared from solid (Sigma-Aldrich, USA); DMA: 
50 As mg/L in-house stock solution of dimethylarsinic acid ((CH3)2AsO(OH)) prepared from solid (Greyhound 
Chromatography, UK); AB: 1031 As mg/L BCR-626 standard solution of arsenobetaine ((CH3)3As+ CH2COO−) 
(LGC, UK).
Total arsenic determination by ICP-MS. Urine samples were thawed at room temperature and refrig-
erated at 4 °C prior to analysis. Due to the high matrix of urine, samples (1 mL) were diluted x10 with 1% v/v 
HNO3 and 0.5% v/v HCl to reduce the effects of high concentrations of sodium (Na) on signal stability. Acidified 
PWS drinking water samples were refrigerated at 4 °C prior to analysis and analysed neat. Total As concentra-
tions in both water and urine samples were determined using inductively coupled plasma mass spectrometry 
(ICP-MS). An Agilent 7500 Series ICP-MS instrument (Agilent Technologies, USA) was used under the operat-
ing conditions described by Watts et al.56. The instrument was fitted with a MicroMist low-flow nebulizer (Glass 
Expansion, Australia) and sample introduction was accelerated using an ASXpress rapid sample introduction 
system (Teledyne CETAC Technologies, USA). A three-point calibration was used with As concentrations at 
1, 10 and 100 μ g/L. Arsenic was detected in helium (He) collision cell mode to reduce potential mass 75 pol-
yatomic interferences such as argon chloride (40Ar35Cl+). A Te internal standard was introduced simultane-
ously via a T-piece and the Te signal response used to fit urinary As data. The limits of detection (LOD) were 
calculated as 3σ of analytical run blanks and were 0.02 and 0.2 As μ g/L for drinking water and urine samples 
respectively.
Arsenic speciation by HPLC-ICP-MS. Urine samples (150 μ L) were diluted × 10 with deionised water and 
As speciation was measured using high performance liquid chromatography coupled to ICP-MS (HPLC-ICP-MS) 
using the method described by Button et al.57. In summary, a GP50 gradient pump and an AS auto-sampler 
(Dionex, USA) were coupled to the ICP-MS instrument with PEEK tubing. Chromatography was performed 
with a PRP-X100 anion exchange column and a PRP-X100 guard column (Hamilton, USA) using gradient elution 
with the mobile phase (pH 8.65, 1 mL/min) alternating between 4 and 60 mM NH4NO3. A 3-point calibration 
was used with 1, 10 and 50 As μ g/L solutions of AsIII and a mixed solution of 1, 10 and 50 As μ g/L AsV, MA, DMA 
and AB. Figure 7 shows a standard chromatogram obtained for calibration solutions. The LODs for this method 
(3σ of blank values) are reported by Watts et al.58: 0.8; 1.5; 0.7; 0.3; 1.3 As μ g/L for AsIII, AsV, MA, DMA and AB 
respectively. It is noted that this method cannot distinguish the trivalent and pentavalent forms of both MA and 
DMA which vary in genotoxicity59.
Urinary dilution measurement and adjustment factor. Urinary osmolality was measured using an 
Osmomat 030 cryoscopic osmometer (Gonotec, Germany). The osmolality of the urine samples was determined 
by comparative measurement of their freezing point with that of pure water. The normalisation procedure applied 
was adapted from that used for creatinine and SG in a recent study on the normalization of urinary drug concen-
trations60, and based on the Levine-Fahy equation61 as follows:
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= ×( )urinary As urinary As osmolality /osmolality ,
where: osmolality is the study population mean urinary osmolality (563 mOsm/kg) (1)
osmolality normalized specimen reference specimen
reference
Quality control (QC). Field duplicates for drinking water (5% of samples) and urine (4% of samples) were 
collected with the following mean percentage differences (where analytes > LOD): drinking water total As: 7% 
(n = 6), urinary total As: 10% (n = 9), AB: 6% (n = 6) and MA: 13% (n = 2). Inter-run duplicates were analysed for 
urinary total As and AB to assess method reproducibility (total As mean percentage difference: 3% (n = 6), AB: 
8% (n = 12). To assess signal stability and the possibility of drift resulting from high urinary matrices, intra-run 
duplicates were analysed for urinary total As and speciation (species > LOD) (total As mean percentage difference: 
8% (n = 5), AB: 2% (n = 5), MA: 2% (n = 1), DMA: 5% (n = 6). Certified reference materials (CRM) were analysed 
with drinking water and urine samples: NIST SRM 1643e Trace Elements in Water (National Institute of Standards 
and Technology, USA) (certified value: 58.98 ± 0.70 As μ g/L, recovery: 100% (n = 4), precision: 3%) and NIES 
No.18 Human Urine (National Institute for Environmental Studies, Japan) (total As certified value: 137 ± 11 As 
μ g/L, recovery: 99% (n = 14), precision: 5%, AB certified value: 69 ± 12 As μ g/L, recovery: 92% (n = 18), precision: 
5%, DMA certified value: 36 ± 9 As μ g/L, recovery: 115% (n = 18), precision: 12%). Independent matrix matched 
QC standards (total As: 5 μ g/L) were also analysed with urine samples (recovery: 94% (n = 16), precision: 8%). 
Background contamination was monitored using run blanks for urine and drinking water analyses, reagent (acid) 
blanks for drinking water analysis and filter blanks for urine analysis. Duplicate measurements were made on 12% 
(n = 25) of urine samples for osmolality with a mean percentage difference of 1%.
Statistical analysis. Statistical analysis (including the production of exploratory plots) was performed 
using R version 3.0.0 (base package)62. Welch’s independent two sample t-test was used to assess the difference 
between results of spot and FMV urine collections. A Shapiro-Wilk test was used to determine the normality of 
exposure and outcome variables before and after applying log transformation. Correlation tests were performed 
using Spearman’s rank correlation coefficient accompanied by a significance test to exclude the possibility of the 
observed correlations resulting from random sampling. Descriptive statistics, with the exception of the geometric 
mean, were obtained using the ‘psych’ package63. In the case of speciation data, where manual peak integration 
resulted in samples with zero or negative values for particular species (AsIII and AsV), left censoring was required 
to enable data for log transformation and the calculation of geometric means. Values < LOD were therefore 
replaced with that of half the appropriate LOD.
Mapping. All maps displayed as figures in this manuscript were compiled using ESRI ArcGIS Desktop version 
10.1. (ArcMap) Environmental Systems Research Institute. Redlands, CA.
Dissemination of results to households. A letter containing individual result data was fed back to 
households. Where a PCV exceedance was highlighted, specific advice was provided to participants on any poten-
tial health risks and suggested corrective actions were given. All participants were provided with appropriate 
contact details for any follow-up enquiries.
The letter and guidance were developed by PHE along with BGS and the Local Authority. The letter was sent 
from the Local Authority, as the regulator for PWS in England.
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